Back to search

University of Patras

Φαρμακοκινητική και φαρμακογενομική ανάλυση της 6-μερκαπτοπουρίνης σε ασθενείς με αιματολογικές κακοήθειες

Abstract

dc:description

The current study is a prospective observational study in order to evaluate the efficacy and toxicity of treatment with 6-MP in patients with ALL, FL-NHL and AML. In this dissertation, 19 patients with different types of leukemia and lymphoma enrolled. The majority of patients (18) hospitalized at the University Hospital of Patras and 1 patient hospitalized at the University Hospital of Ioannina. According to the ethics rules and upon patients’ approval, the appropriate samples were collected.Patients devided into two groups; group one includes patients that were treated with 6-MP during thesis and the second group patients that had already completed their treatment during thesis. All patients treated with 6-MP according to the standard procedure. High performance liquid chromatography (HPLC) was used for the samples’ analysis of patients that were received 6-MP during the thesis, for determining the levels of 6-MP and its metabolites, 6-MMP and 6-TG. In doth groups of patients VNTR genotyping of gene TPMT was performed. The goals of this thesis were the better understanding of the distribution of 6-TGs and 6-MMPs and the reveal of VNTR polymorphisms for helping the improvevement of the design better regimens of 6-MP. Also, the characterization of Greek population regarding VNTR polymorphisms was approached.Blood samples were collected in a time-dependent manner during the typical appointment of patients with their haematologist. This was followed by laboratory analysis of samples, which were determined qualitatively and quantitatively haematological parameters as well as the metabolites of 6-MP. Among the patients who enrolled in the study, 8 samples were from group one and 11 were from group two. Pharmacokinetic studies were performed in group one and analysis for polymorphisms in the VNTR promoter of the TPMT gene in both groups.Although the number of patients in this thesis is restricted, it is very important to understand the distribution of metabolites of 6-MP as well as the existence of TPMT gene polymorphisms in patients with haematological malignancies because it will improve the performance regimens of 6-MP and reducing toxicity. In the current thesis, the pharmacokinetic analysis of 6-MP metabolites reveal a trend for heterogenicity regarding toxicity of 6-MP. This is can be explained with pharmacogenomics analysis and other agents’ coadministration, partially. The TPMT genetic variants might not be adequate to explain all patients’ cases. More studies have to be performed including other genes besides TPMT. In addition, this thesis indicates how important factor is nationality to develop a genomic profile of a population. The growing scientific interest in the impact of140ethnicity in detecting polymorphisms thought to give this factor the same value that are other conventional factors considered in the studies, such as gender, age, etc.

Degree

thesis:*
Grantor dc:publisher
University of Patras
Year dc:date
2015

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Vicha, Anna
  • Βήχα, Άννα

Subjects

dc:subject × 6

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/36098

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Vicha, Anna; Βήχα, Άννα. Φαρμακοκινητική και φαρμακογενομική ανάλυση της 6-μερκαπτοπουρίνης σε ασθενείς με αιματολογικές κακοήθειες. University of Patras, 2015. http://hdl.handle.net/10442/hedi/36098